Breathalyzer and Drug Testing Equipment Market - 2023-2031

November 2025 | 243 pages | ID: BFA5B2877784EN
DataM Intelligence

Abstracts

The Breathalyzer and Drug Testing Equipment Market was valued at US$ 8.43 billion in 2023 and is anticipated to reach US$ 19.01 billion by 2031, at a CAGR of 0.111 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Breathalyzer and Drug Testing Equipment Market.

This report delivers a comprehensive overview of the Breathalyzer and Drug Testing Equipment Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Breathalyzer and Drug Testing Equipment Market. The Breathalyzer and Drug Testing Equipment Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2031.

Breathalyzer and Drug Testing Equipment Market Scope:

By Type

• Urine Drug Testing Devices
• Oral Fluid Drug Testing Devices
• Hair Drug Testing Devices
• Blood Drug Testing Devices
• Breathalyzers
• Others

By Usage

• Preliminary Alcohol Screening
• Evidential Breath Testing
• Home Testing
• Workplace Testing
• Forensic Testing
• Clinical Testing

By Modality

• Point-of-Care Testing (POCT)
• Laboratory Testing
• At-Home Test Kits
• On-Site Testing Kits
• Clinical Testing

By End User

• Law Enforcement Agencies
• Hospitals & Laboratories
• Rehabilitation Centers
• Educational and Workplaces
• Others

Key Players

• Abbott
• Dragerwerk AG & Co. KGaA
• Quest Diagnostics
• BACtrack
• Intoximeters
• Accuquik Test Kits
• Siemens Healthcare Private Limited
• Roche Diagnostics Limited.
• C4 Development
• Cannabix Technologies Inc.

Major Highlights

This report delivers a comprehensive overview of the Breathalyzer and Drug Testing Equipment Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Breathalyzer and Drug Testing Equipment Market. The Breathalyzer and Drug Testing Equipment Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2031.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Type
3.2. Snippet by Usage
3.3. Snippet by Modality
3.4. Snippet by End User

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Rising road accidents under the influence of drugs
    4.1.1.2. Technological advancements in the drug testing equipment
  4.1.2. Restraints
    4.1.2.1. Inaccurate results of the equipment
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. COVID-19 ANALYSIS

6.1. Analysis of COVID-19
  6.1.1. Scenario Before COVID
  6.1.2. Scenario During COVID
  6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. BY TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  7.1.2. Market Attractiveness Index, By Type
7.2. Urine Drug Testing Devices*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Oral Fluid Drug Testing Devices
7.4. Hair Drug Testing Devices
7.5. Blood Drug Testing Devices
7.6. Breathalyzers
  7.6.1. Fuel Cell Breathalyzers
  7.6.2. Semi-Conductor Breathalyzers
  7.6.3. IR-Spectroscopy Breathalyzers
  7.6.4. Others
7.7. Others

8. BY USAGE

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
  8.1.2. Market Attractiveness Index, By Usage
8.2. Preliminary Alcohol Screening*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Evidential Breath Testing
8.4. Home Testing
8.5. Workplace Testing
8.6. Forensic Testing
8.7. Clinical Testing

9. BY MODALITY

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  9.1.2. Market Attractiveness Index, By Modality
9.2. Point-of-Care Testing (POCT)*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Laboratory Testing
9.4. At-Home Test Kits
9.5. On-Site Testing Kits
9.6. Clinical Testing

10. BY END USER

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  10.1.2. Market Attractiveness Index, By End User
10.2. Law Enforcement Agencies*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Hospitals & Laboratories
10.4. Rehabilitation Centers
10.5. Educational and Workplaces
10.6. Others

11. BY REGION

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  11.1.2. Market Attractiveness Index, By Region
11.2. North America
  11.2.1. Introduction
  11.2.2. Key Region-Specific Dynamics
  11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
  11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
  11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.2.7.1. The U.S.
    11.2.7.2. Canada
    11.2.7.3. Mexico
11.3. Europe
  11.3.1. Introduction
  11.3.2. Key Region-Specific Dynamics
  11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
  11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
  11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.3.7.1. Germany
    11.3.7.2. UK
    11.3.7.3. France
    11.3.7.4. Italy
    11.3.7.5. Spain
    11.3.7.6. Rest of Europe
11.4. South America
  11.4.1. Introduction
  11.4.2. Key Region-Specific Dynamics
  11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
  11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
  11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.4.7.1. Brazil
    11.4.7.2. Argentina
    11.4.7.3. Rest of South America
11.5. Asia-Pacific
  11.5.1. Introduction
  11.5.2. Key Region-Specific Dynamics
  11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
  11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
  11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.5.7.1. China
    11.5.7.2. India
    11.5.7.3. Japan
    11.5.7.4. South Korea
    11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
  11.6.1. Introduction
  11.6.2. Key Region-Specific Dynamics
  11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
  11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
  11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users

12. COMPETITIVE LANDSCAPE

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. COMPANY PROFILES

13.1. Abbott
  13.1.1. Company Overview
  13.1.2. Product Portfolio and Description
  13.1.3. Financial Overview
  13.1.4. Key Developments
13.2. Dr?gerwerk AG & Co. KGaA
13.3. Quest Diagnostics
13.4. BACtrack
13.5. Intoximeters
13.6. Accuquik Test Kits
13.7. Siemens Healthcare Private Limited
13.8. Roche Diagnostics Limited.
13.9. C4 Development
13.10. Cannabix Technologies Inc. (LIST NOT EXHAUSTIVE)

14. APPENDIX

14.1. About Us and Services
14.2. Contact Us